Dr. Andrew Rut, CEO of MyMeds&Me speaks to The Pharma Letter
Is Big Data Always Good Data?
MyMeds&Me attend DIA Global Meeting 2018 in Boston
Dr. Andrew Rut, CEO of MyMeds&Me, will be speaking at FutureLink Conference in Munich
Andrew Rut, CEO of MyMeds&Me shares his thoughts on Brexit’s impact on clinical trials
New big data rules threaten effective drug development
New ‘tech’ on the block: The critical role of new tech in advancing patient autonomy and drug development.
Andrew Rut, CEO of MyMeds&Me, speaks to the Pharmaceutical Journal
To find out more or request a demo fill in the details below:
We use analytical cookies that need your permission. For more details and advanced options view our Cookies Policy.